Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial

por Yang, Wenying, Min, Kyungwan, Zhou, Zhiguang, Li, Ling, Xu, XiangJin, Zhu, Dalong, Venkateshwar Rao, A., Murthy, Laxminarayanappa Sreenivasa, Zhang, Nianxian, Li, Ivy, Niemoeller, Elisabeth, Shang, Shuhua
Publicado 2017